亨迪药业:关于2025年半年度利润分配预案的公告

Core Viewpoint - Hendi Pharmaceutical announced a profit distribution plan for the first half of 2025, proposing a stock dividend and a capital reserve increase for shareholders [2] Group 1: Profit Distribution Plan - The company plans to distribute cash dividends of 0 RMB per 10 shares (including tax) to all shareholders [2] - No bonus shares will be issued, with a proposal to increase capital reserves by 4.5 shares for every 10 shares held [2] - The proposal is subject to approval at the company's first extraordinary general meeting of shareholders in 2025 [2]

BIOCAUSE HEILEN PHARMA-亨迪药业:关于2025年半年度利润分配预案的公告 - Reportify